METHOD OF PREPARATION
Note: This preparation should be prepared in a laminar airflow hood in a cleanroom or vin isolation barrier technology by a validated aseptic compounding pharmacist 'using strict aseptic technique. This is a high-risk preparation.
1. Calculate the required quantity of each ingredient for the total amount to be prepared.
2. Accurately weigh and/or measure each ingredient.
3. Dissolve the gabapentin and sodium chloride in sufficient sterile water for injection to volume and mix well.
4. Filter through a sterile 0.20 -µm filter into individual-dose sterile vials or single-use syringes.
5. Package and label.
PACKAGING
Package in tight, light-resistant containers.1
LABELING
Keep out of reach of children. Use only as directed. Store in a refrigerator.
STABILITY
Tf not sterility tested: A bcyond-usc date of up to 24 hours at room temperature, up to 3 days at refrigerated temperature (2 to 8°C), or up to 45 days if frozen can be used for this preparation.1
If sterility tested: A beyond-use date of up to 14 days stored in a refrigerator can be used for this preparation.1
USE
Gabapentin injection is used in the treatment of neuropathic pain.
QUALITY CONTROL
Quality-control assessment can include weight/volume, physical observation, pH, specific gravity, osmolality, assay, color, clarity, paniculate matter, sterility and pyrogenicity.2,3
DISCUSSION
Gabapentin is an anticonvulsant structurally related to the central nervous system neurotransmitter γ-aminobutyric acid. It is used as an antiepileptic that is effective in the treatment of partial seizures with or without secondary generalization and is used as adjunctivc therapy in patients unresponsive to or intolerant of standard antiepileptic drugs. It is vised in the treatment of neuropathic pain in adults, with doses titrated to a maximum of 1.8 g daily in three divided doses. In renal impairment, reduced doses are recommended. It has also been used in the treatment of headache, postherpetic neuralgia, multiple sclerosis and Parkinsonism.4
Gabapentin (C^sub 9^H^sub 17^NO^sub 2^, MW 171.24) is not an official substance in the United States Pharmacopeia. It occurs as white crystals that melt at about 164 to 167°C. Tt has two pK^sub a^ values, one at 3.68 and one at 10.7. It is soluble greater than 100 mg/mL in water at pH 7.4.5
Sodium chloride (NaCl, MW 58.44) is available as a white crystalline powder or as colorless crystals. It has a saline taste and is used in a variety of parenteral and nonparenteral pharmaceutical formulations. In parenteral, ophthalmic and nasal preparations, it is used to prepare isotonic solutions. It is also used as a capsule diluent and lubricant and as a means of controlling drug release from some microcapsules, controlling micelle size and adjusting the viscosity of some polymer dispersions by altering the ionic character of the formulation. The pH of a saturated solution is in the range of 6.7 to 7.3, and it is soluble in water (l g in 2.8 m L), glycerin (1 g in 10 mL) and 95% ethanol (l g in 250 mL). A 0.9% w/v aqueous solution is iso-osmotic with serum, and its solutions are stable. Its solutions are corrosive to iron and will react to form precipitates with silver, lead and mercury salts. Chlorine can be liberated in the presence of strong oxidizing agents from its acidified solutions. It can also decrease the solubility of methylparaben in aqueous solution.6
Sterile water for injection is water for injection that has been sterilized and suitably packaged; it contains no added substances.1
REFERENCES
1. United States Pharmacopeial Convention, Inc. United States Pharmacopeia 27-Nationa/Formulary22. Rockville, MD: US Pharmacopeial Convention, Inc.; 2004: 785-786,1950,2345-2349.
2. Alien LV Jr. Standard operating procedure for particulate testing for sterile products. /JPC1998; 2(1): 78.
3. Alien LV Jr. Standard operating procedure: Quality assessment for injectable solutions./JPC1999; 3(5): 406-407.
4. Sweetman SC, ed. MAHTINDALE: The Complete Drug Reference. 33rd ed. London: The Pharmaceutical Press; 2002: 350-351.
5. White HS. Antiepileptic drugs. In: Gennaro AR. Remington: The Science and Practice of Pharmacy. 20th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2000:1425.
6. Owen SC. Sodium chloride. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003: 556-559.
Copyright International Journal of Pharmaceutical Compounding Jan/Feb 2005
Provided by ProQuest Information and Learning Company. All rights Reserved